These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2080 related items for PubMed ID: 19213860

  • 21. Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity.
    Zandman-Goddard G, Blank M, Langevitz P, Slutsky L, Pras M, Levy Y, Shovman O, Witte T, Doria A, Rovensky J, Shoenfeld Y.
    Ann Rheum Dis; 2005 Dec; 64(12):1698-702. PubMed ID: 16014675
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus.
    Hanly JG, Thompson K, McCurdy G, Fougere L, Theriault C, Wilton K.
    J Immunol Methods; 2010 Jan 31; 352(1-2):147-52. PubMed ID: 19836394
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
    Marto N, Bertolaccini ML, Calabuig E, Hughes GR, Khamashta MA.
    Ann Rheum Dis; 2005 Mar 31; 64(3):444-8. PubMed ID: 15286009
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus.
    Bruns A, Bläss S, Hausdorf G, Burmester GR, Hiepe F.
    Arthritis Rheum; 2000 Oct 31; 43(10):2307-15. PubMed ID: 11037891
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
    Amoura Z, Koutouzov S, Chabre H, Cacoub P, Amoura I, Musset L, Bach JF, Piette JC.
    Arthritis Rheum; 2000 Jan 31; 43(1):76-84. PubMed ID: 10643702
    [Abstract] [Full Text] [Related]

  • 32. Diagnostic performance and clinical associations of antibodies to the chromatin antigenic system in juvenile systemic lupus erythematosus.
    Keusseyan SP, da Silva NP, Hilário MO, Okuda EM, Terreri MT, Andrade LE.
    Rev Bras Reumatol; 2012 Oct 31; 52(5):695-712. PubMed ID: 23090370
    [Abstract] [Full Text] [Related]

  • 33. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A, Kalaaji M, Haugbro K, Nikolaisen C, Nilsen K, Rekvig OP, Nossent JC.
    Arthritis Res Ther; 2006 Oct 31; 8(6):R162. PubMed ID: 17062137
    [Abstract] [Full Text] [Related]

  • 34. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus.
    Hoffman IE, Lauwerys BR, De Keyser F, Huizinga TW, Isenberg D, Cebecauer L, Dehoorne J, Joos R, Hendrickx G, Houssiau F, Elewaut D.
    Ann Rheum Dis; 2009 Mar 31; 68(3):412-5. PubMed ID: 18930995
    [Abstract] [Full Text] [Related]

  • 35. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus.
    Husebye ES, Sthoeger ZM, Dayan M, Zinger H, Elbirt D, Levite M, Mozes E.
    Ann Rheum Dis; 2005 Aug 31; 64(8):1210-3. PubMed ID: 15708887
    [Abstract] [Full Text] [Related]

  • 36. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.
    Morgan PE, Sturgess AD, Davies MJ.
    Arthritis Rheum; 2005 Jul 31; 52(7):2069-79. PubMed ID: 15986354
    [Abstract] [Full Text] [Related]

  • 37. Anti-nucleosome antibodies in patients with systemic lupus erythematosus: potential utility as a diagnostic tool and disease activity marker and its comparison with anti-dsDNA antibody.
    Saigal R, Goyal LK, Agrawal A, Mehta A, Mittal P, Yadav RN, Meena PD, Wadhvani D.
    J Assoc Physicians India; 2013 Jun 31; 61(6):372-7. PubMed ID: 24640201
    [Abstract] [Full Text] [Related]

  • 38. The pathogenetic role of immunoglobulin G from patients with systemic lupus erythematosus in the development of lupus pleuritis.
    Guo H, Leung JC, Chan LY, Chan TM, Lai KN.
    Rheumatology (Oxford); 2004 Mar 31; 43(3):286-93. PubMed ID: 14623950
    [Abstract] [Full Text] [Related]

  • 39. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q.
    Mok CC, Birmingham DJ, Ho LY, Hebert LA, Song H, Rovin BH.
    Lupus; 2012 Jan 31; 21(1):36-42. PubMed ID: 21993384
    [Abstract] [Full Text] [Related]

  • 40. Measurement of autoantibodies in pediatric-onset systemic lupus erythematosus and their relationship with disease-associated manifestations.
    Gilliam BE, Ombrello AK, Burlingame RW, Pepmueller PH, Moore TL.
    Semin Arthritis Rheum; 2012 Jun 31; 41(6):840-8. PubMed ID: 22177108
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 104.